Opendata, web and dolomites

SURE SIGNED

3-D Super resolution Ultrasound Real time imaging of Erythrocytes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SURE project word cloud

Explore the words cloud of the SURE project. It provides you a very rough idea of what is the project "SURE" about.

capillary    resolution    perfusion    diagnoses    paradigm    scientific    leads    imaging    detecting    time    frame    hundreds    treatment    cancer    dimensional    rates    volumetric    repeated    yield    shift    probes    agents    screening    data    erythrocytes    disease    volume    flow    clinical    individual    ultrasound    motion    volumes    full    performed    levels    thereby    diagnosis    injection    goals    cm    deep    ultrafast    anatomy    human    column    contrast    blood    quantification    adverse    trials    synthetic    aperture    faster    million    vascular    coded    newborns    gradient    micrometer    times    normal    estimation    breakthroughs    elderly    hz    tracks    rodents    cells    effort    row    visualizing    pressure    13    population    sure    body    isotropic    super    synergistic    silicon    groups    diagnostic    directions    visualization    humans    possibility    400    diabetes    resolving    gbytes    combing    learning    tracking    2600    red    attained   

Project "SURE" data sheet

The following table provides information about the project.

Coordinator
DANMARKS TEKNISKE UNIVERSITET 

Organization address
address: ANKER ENGELUNDSVEJ 1 BYGNING 101 A
city: KGS LYNGBY
postcode: 2800
website: www.dtu.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 9˙980˙899 €
 EC max contribution 9˙980˙899 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2019-SyG
 Funding Scheme ERC-SyG
 Starting year 2020
 Duration (year-month-day) from 2020-03-01   to  2026-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) coordinator 7˙384˙019.00
2    REGION HOVEDSTADEN DK (HILLEROD) participant 1˙431˙565.00
3    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 1˙165˙315.00

Map

 Project objective

'The SURE project: 'Super resolution Ultrasound Real time imaging of Erythrocytes' will develop and research a new super resolution ultrasound imaging method capable of resolving capillary flow in the human body. The approach tracks the motion of the individual red blood cells (erythrocytes) in a three-dimensional volume for a full visualization of anatomy, flow, and perfusion in a volume down to 13 cm at 20 volumes per second. The super resolution imaging is performed without using contrast agents and is thereby 2600 times faster than current methods. The method has an isotropic resolution of 50 micrometer in all directions, and the volumetric resolution is thereby 100-400 times better than current state-of-the-art 3-D ultrasound imaging. These highly ambitious goals are attained in a synergistic research effort combing four research groups. The scientific project includes breakthroughs in silicon row-column probes with 1 million elements, advanced synthetic aperture ultrafast coded imaging, deep learning for detecting and tracking of cells, pressure gradient estimation, and visualization and quantification of several hundreds of Gbytes volumetric data. The research finally leads to clinical trials conducted on rodents and humans for studying the changes in perfusion for diabetes and cancer. The SURE imaging approach can yield a paradigm shift in the scientific study, diagnoses, and treatment of cancer, diabetes, and vascular disease at the capillary level, as it enables the possibility of volumetric visualizing capillary perfusion in real-time at frame rates above 20 Hz without injection of contrast agents. Imaging is performed using ultrasound at normal diagnostic levels with no known adverse effects and can, thus, be used on a wide range of the population from newborns to the elderly for both diagnosis and repeated screening.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

AST (2019)

Automatic System Testing

Read More  

CARBYNE (2020)

New carbon reactivity rules for molecular editing

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More